Filing Details

Accession Number:
0001708138-17-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-05 16:52:38
Reporting Period:
2017-06-01
Filing Date:
2017-06-05
Accepted Time:
2017-06-05 16:52:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226689 Neil Stahl 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research And Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-01 4,527 $268.40 28,477 No 4 M Direct
Common Stock Disposition 2017-06-01 2,612 $464.98 25,865 No 4 F Direct
Common Stock Disposition 2017-06-01 1,068 $464.98 24,797 No 4 F Direct
Common Stock Acquisiton 2017-06-01 6,017 $145.70 30,814 No 4 M Direct
Common Stock Disposition 2017-06-01 1,885 $464.98 28,929 No 4 F Direct
Common Stock Disposition 2017-06-01 2,167 $464.98 26,762 No 4 F Direct
Common Stock Disposition 2017-06-02 100 $466.33 26,662 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $469.83 26,562 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $470.49 26,462 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $472.10 26,362 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $474.82 26,262 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $475.33 26,162 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $476.52 26,062 No 4 S Direct
Common Stock Disposition 2017-06-02 100 $479.00 25,962 No 4 S Direct
Common Stock Disposition 2017-06-02 309 $480.71 25,653 No 4 S Direct
Common Stock Disposition 2017-06-02 695 $481.64 24,958 No 4 S Direct
Common Stock Disposition 2017-06-02 808 $482.56 24,150 No 4 S Direct
Common Stock Disposition 2017-06-02 200 $483.42 23,950 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-06-01 6,017 $0.00 6,017 $145.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-06-01 4,527 $0.00 4,527 $268.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-28 2017-12-17 No 4 M Direct
0 2013-11-10 2017-12-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,000 Indirect by GRAT
Common Stock 5,000 Indirect by GRAT
Common Stock 5,647 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 309 shares of Company stock on June 2, 2017 at prices ranging from $480.30 to $480.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
  3. Represents volume-weighted average price of sales of 695 shares of Company stock on June 2, 2017 at prices ranging from $481.25 to $481.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
  4. Represents volume-weighted average price of sales of 808 shares of Company stock on June 2, 2017 at prices ranging from $482.00 to $482.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
  5. Represents volume-weighted average price of sales of 200 shares of Company stock on June 2, 2017 at prices ranging from $483.11 to $483.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.